rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Rediff News  All News 

Drug Controller General Of India And Bharat Biotech

Rediff.com  »  News  »   Drug Controller General Of India And Bharat Biotech

  News for Drug Controller General Of India And Bharat Biotech

  • News
  • Business

Govt extends gap between 2 doses of Covishield to 12-18 weeks

The Centre on Thursday approved extending the gap between the two doses of the Covishield vaccine to 12-16 weeks following a recommendation from a government panel, and said it is a 'science-based......

DGCI approves Covaxin for phase 2/3 trials on children

India's apex drug regulator has granted permission for conducting the phase II/III clinical trial of Bharat Biotech's Covaxin COVID-19 vaccine in the age group of 2 to 18 years, the Union Health......

SII to raise monthly production to 10 cr doses by Aug, Bharat Biotech promises 7.8 cr

Amid multiple states reporting a shortage of COVID-19 vaccine, Serum Institute and Bharat Biotech have submitted to the Centre their production plan for the next four months, informing they can......

'No preparedness planning, no accountability, no action plan'

'This government did not have any plan for safety stocks of essential medicines.' IMAGE: Doctors attend to a patient suffering from COVID-19 inside the emergency room at the Safdarjung Hospital in......

How Serum and Bharat battled for COVID-19 vaccine

There were apprehensions in the SII about rival Bharat Biotech's 'indigenous' tag, opening up shortcuts for it.One senior person, who was very familiar with the sector, told me, 'The message has......

Air freight stations planned to transport Covid vaccines

The government is considering setting up air freight stations to enable direct movement of vaccines from pharmaceutical factories to the aircraft. From reducing dwell time at airports to faster......

Will India's Covaxin be world's first COVID-19 drug?

'We need to prove to the world that quality vaccines and R&D are possible in India.' *Photograph: Carl Recine/Reuters. Dr Krishna Ella, chairman and MD, Bharat Biotech, is the man of the moment.......

Serum Institute's race to produce COVID-19 vaccine

'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'Ritwik Sharma reports. IMAGE: A quality control test conducted at the Serum......

Chidambaram's Budget speech

Speech of P. Chidambaram Minister of Finance PART A Mr. Speaker, Sir, I rise to present the Budget for the year 2005-06. 2. Last year, while presenting the Budget, I had suggested that the vote in......
  Web results for Drug Controller General Of India And Bharat Biotech
DGCI approves Covaxin for phase 2/3 trials on children

India's apex drug regulator has granted permission for conducting the phase II/III clinical trial of Bharat Biotech's Covaxin COVID-19 vaccine in... ...

http://www.rediff.com/news/report/dgci-approves-covaxin-for-phase-23-trials-on-kids/20210513.htm
Serum Institute says will raise monthly production to 10 crore doses by August, Bharat Biotech promises 7.8 crore

The stock of Covaxin in Delhi has finished and as a result around 100 vaccination centres set up in 17 schools have been closed, Sisodia said. Amid... ...

https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/serum-institute-says-will-raise-monthly-production-to-10-cr-doses-by-august-bharat-biotech-promises-7-8-crore/articleshow/82576477.cms
'No preparedness planning, no accountability, no action plan'

'This government did not have any plan for safety stocks of essential medicines.' IMAGE: Doctors attend to a patient suffering from COVID-19... ...

http://www.rediff.com/news/interview/kiran-mazumder-shaw-covid-19-no-preparedness-planning-no-action-plan/20210508.htm
J&J seeks permission for trial of 1-shot Covid vaccine in India

Global healthcare major Johnson & Johnson on Tuesday said it has sought an approval from the India's drug regulator to conduct a bridging clinical... ...

http://www.rediff.com/news/report/jj-seeks-permission-for-covid-vaccine-trial-in-india/20210420.htm
Government's expert panel allows clinical trials for third dose of Covaxin

Bharat Biotech presented amendments to the subject expert committee of the Drugs Controller General of India (DCGI) in the approved Phase 2... ...

https://timesofindia.indiatimes.com/india/covid-19-governments-expert-panel-allows-clinical-trials-for-third-dose-of-covaxin/articleshow/81869259.cms

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z